Search Results 161-170 of 17508 for CLL

  1. Talal Hilal, M.D. - Doctors and Medical Staff - Mayo Clinic

    Talal Hilal, M.D., is a hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid ...

  2. Jose F. Leis, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    MemberChronic Lymphocytic Leukemia Core Group (CLL), Division of Hematology/Oncology, Department of Internal Medicine. 2007 - present. MemberMayo Clinic ...

  3. Non-Hodgkin lymphoma - Symptoms and causes - Mayo Clinic

    Chronic lymphocytic leukemia · Cutaneous B-cell lymphoma · Cutaneous T-cell lymphoma · Diffuse large B-cell lymphoma · Follicular lymphoma · Mantle cell ...

  4. Yucai Wang, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Wang has a particular interest in mantle cell lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia. He is dedicated to improving ...

  5. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.

  6. Clinical trials - Oncology (Medical)

    ... Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of this study is to assess the safety and tolerability ...

  7. Grzegorz S. Nowakowski, M.D. - Mayo Clinic Faculty Profiles

    Nowakowski is focused on the identification of novel prognostic markers in chronic lymphocytic leukemia using phage display peptide libraries. Dr ...

  8. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...

  9. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  10. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... Chronic lymphocytic leukemia/ Small lymphocytic lymphoma (CLL/SLL) with * At least 2 lines of prior therapy (Part 1 only) * Part 2 Cohort A: CLL/SLL ...